Welcome to our dedicated page for Radnet SEC filings (Ticker: RDNT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
RadNet, Inc. filings document material-event disclosures for operating results, financial condition, governance, capital structure, and corporate actions tied to its diagnostic imaging and digital health businesses. Recent Form 8-K reports furnish quarterly results press releases and exhibits, including segment information for Imaging Centers and Digital Health.
The company’s proxy materials address board matters, executive compensation, and shareholder voting items. Other filings include leadership and compensatory-arrangement disclosures, prospectus supplements under automatic shelf registration statements for common stock resale registrations, and acquisition-related share issuance matters associated with RadNet’s health informatics expansion.
RadNet EVP and Chief Science Officer Alma Gregory Sorensen reported a charitable donation of 5,600 shares of common stock on June 17, 2025. The transaction was executed at $0 as it was a gift (Transaction Code: G).
Following the transaction, Sorensen maintains direct beneficial ownership of 1,165,345 shares of RadNet common stock. The filing indicates that Sorensen serves in dual roles as both a Director and Executive Officer (EVP, Chief Science Officer) of the company.
Key Transaction Details:
- Transaction Type: Charitable Donation
- Direct Ownership Maintained
- No derivative securities were involved in this transaction
- Filing was signed by Jose Gamez as Attorney-in-Fact on June 18, 2025